US 11603351
Carboxamides as modulators of sodium channels
granted A61KA61K31/165
Quick answer
US patent 11603351 (Carboxamides as modulators of sodium channels) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Mar 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/165